Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
Lilly To Provide Free Access to Drug Discovery Platform Under New Collaborative Initiative
June 15, 2009
Findings from the initiative "could ultimately form the basis for collaboration or licensing agreements between Lilly and external institutions," the company said.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register quickly here for free access.
New to GenomeWeb? Register quickly here for free access.
Related Stories
- Lilly Readies Web Portal for PD2 Initiative; University of Cincinnati Joins List of Participants
- News Scan
- NCATS Launches Drug Repurposing Project with Big Pharma, Investigators
May 3, 2012 / GenomeWeb Daily News - Merck Serono Survey Finds Limited Test Access, High Costs a Barrier to Personalized Rx Adoption in UK
May 2, 2012 / Pharmacogenomics Reporter - After FDA Letter Seeking More Data, Lilly Won't Pursue CDx-Guided Erbitux in NSCLC in the US
May 2, 2012 / Pharmacogenomics Reporter